Early buyers will receive 10% customization on this report.
This report studies the global mass spectrometry market for the forecast period of 2015 to 2020. This market is expected to reach USD 7,279.1 Million by 2020 from USD 4,919.9 in 2015 at a CAGR of 8.1% during the forecast period.
The global mass spectrometry market is segmented on the basis of platform, application, and region.
Based on platform, the mass spectrometry market is categorized into hybrid mass spectrometry, single mass spectrometry and other mass spectrometry. In 2015, hybrid mass spectrometry segment is estimated to account for the major share of the mass spectrometry market.
Based on application, the market is segmented into pharmaceuticals, biotechnology, industrial chemistry, environmental testing, food & beverage testing, and others. In 2015, the pharmaceuticals segment is estimated to account for the major share of the mass spectrometry market.
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
In 2015, North America is expected to account for the largest share of the mass spectrometry market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering mass spectrometry equipment.
Some major players in the global mass spectrometry market include Agilent Technologies (U.S.), Danaher Corporation (U.S.), PerkinElmer (U.S.), Thermo Fisher Scientific (U.S.), Bruker Corporation (U.S), Waters Corporation (U.S), Shimadzu Corporation (Japan), Leco Corporation (U.S.), Dani Instruments S.P.A. (Italy), and Kore Technologies, Ltd. (U.K.).
About MarketsandMarkets:
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit www.marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
